<?xml version="1.0" encoding="utf-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:types="http://xbrl.frc.org.uk/general/2019-01-01/types" xmlns:uk-ref="http://xbrl.frc.org.uk/general/2019-01-01/ref" xmlns:common="http://xbrl.frc.org.uk/general/2019-01-01/common" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:curr="http://xbrl.frc.org.uk/cd/2019-01-01/currencies" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:countries="http://xbrl.frc.org.uk/cd/2019-01-01/countries" xmlns:lang="http://xbrl.frc.org.uk/cd/2019-01-01/languages" xmlns:bus="http://xbrl.frc.org.uk/cd/2019-01-01/business" xmlns:accrep="http://xbrl.frc.org.uk/reports/2019-01-01/accrep" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:aurep="http://xbrl.frc.org.uk/reports/2019-01-01/aurep" xmlns:Q1="http://xbrl.org/2005/xbrldt" xmlns:direp="http://xbrl.frc.org.uk/reports/2019-01-01/direp" xmlns:core="http://xbrl.frc.org.uk/fr/2019-01-01/core" xmlns:FRS-102="http://xbrl.frc.org.uk/FRS-102/2019-01-01" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2010-04-20" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="application/xhtml+xml; charset=UTF-8" http-equiv="Content-Type" /><title>Maylands_Healthcare_Limit - Accounts</title><style type="text/css">@page land { size:landscape; }@page port { size:portrait; }.pageFirst { page-break-after:always;  background-color:white;    border-top:1px solid black;  border-bottom:1px solid black;    border-left:1px solid black;    border-right:1px solid black;   } .portraitPage {    page:port;  width:21cm; height:29.7cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } .landscapePage {  page:land;  width:29.7cm; height:21cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } a.tooltip {color:black;text-decoration:none}a.tooltip span{display:none}a.tooltip:hover span{display:inline;position:absolute;z-index:5002;background:#ffffff}a.anchor {color:blue;}a.tooltipRTF {color:black;text-decoration:none;display:none}span:hover a.tooltipRTF {display:block;position:absolute;background:#ffffff}span.tooltipRTFtext {position:absolute;left:10;width:200;border:1pt solid black;text-align:left;font-weight:normal;z-index:5002;bottom:20;font-family:Arial;font-size:9;background-color:#FFFFCC; }.c,.crn,.cjn,.cln,.ccn,.crb,.cjb,.clb,.ccb,.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{position:absolute;word-wrap:break-word}.crn,.cjn,.cln,.ccn,.crni,.cjni,.clni,.ccni{font-weight:normal}.crb,.clb,.cjb,.ccb,.crbi,.cjbi,.clbi,.ccbi{font-weight:bold}.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{font-style:italic}.crn,.crb,.crni,.crbi{text-align:right}.cln,.clb,.clni,.clbi{text-align:left}.ccn,.ccb,.ccni,.ccbi{text-align:center}.cjn,.cjb,.cjni,.cjbi{text-align:justify}.fn0{font-size:0px}.fn1{font-size:9.6px;font-family:Arial}.fn2{font-size:27.7px;font-family:Arial}.fn3{font-size:18.1px;font-family:Arial}.fn4{font-size:9.1px;font-family:Arial}.fn5{font-size:16px;font-family:Arial}.fn6{font-size:13.3px;font-family:Arial}.fn7{font-size:6.4px;font-family:Arial}.fn8{font-size:10.7px;font-family:Arial}.fn9{font-size:0px;font-family:Arial}.sln{border-top:1px solid black}.dln{border-top:4px double black}.u{text-decoration:underline}ul,li{ margin-top:0px;margin-bottom:0px;margin-right:0px;margin-left:8px;   padding-top:0px;padding-bottom:0px;padding-right:0px;padding-left:8px;} </style></head><body xml:lang="en" style="background-color:white"><div class="pageFirst" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="crn fn2" style="top:164.49pt;left:46.61pt;width:417.55pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="crn fn3" style="top:203.22pt;left:46.61pt;width:417.55pt;"><ix:nonNumeric contextRef="C" name="bus:ReportTitle">Unaudited Financial Statements</ix:nonNumeric></div><div class="crn fn3" style="top:232.66pt;left:46.61pt;width:417.55pt;">For Filing with Registrar</div><div class="crn fn3" style="top:262.08pt;left:46.61pt;width:417.55pt;">For the year ended 30 September 2019</div><div class="crn fn4" style="top:628.66pt;left:46.61pt;width:417.55pt;"><ix:nonNumeric contextRef="C" name="bus:CountryFormationOrIncorporation"></ix:nonNumeric>Company Registration No. <ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">07579931</ix:nonNumeric> (England and Wales)</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn5" style="top:40.01pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="cln fn5" style="top:54.9pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:69.79pt;left:46.61pt;width:420.77pt;">Company Information</div><div class="cln fn7" style="top:82.2pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:88.15pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn8" style="top:125.38pt;left:46.61pt;width:115.49pt;">Directors</div><div class="cln fn8" style="top:125.38pt;left:159.11pt;width:141.7pt;"><ix:nonNumeric contextRef="C_BK_BL" name="bus:NameEntityOfficer">Dr A. Aggarwal</ix:nonNumeric></div><div class="cln fn8" style="top:125.38pt;left:300.81pt;width:145.43pt;"></div><div class="cln fn8" style="top:136.6pt;left:159.11pt;width:141.7pt;"><ix:nonNumeric contextRef="C_BK_BN" name="bus:NameEntityOfficer">Dr H. Jenkins</ix:nonNumeric></div><div class="cln fn8" style="top:136.6pt;left:300.81pt;width:145.43pt;"></div><div class="cln fn8" style="top:147.82pt;left:159.11pt;width:141.7pt;"><ix:nonNumeric contextRef="C_BK_BO" name="bus:NameEntityOfficer">Dr N. Rao</ix:nonNumeric></div><div class="cln fn8" style="top:147.82pt;left:300.81pt;width:145.43pt;"></div><div class="cln fn8" style="top:159.05pt;left:159.11pt;width:141.7pt;"><ix:nonNumeric contextRef="C_BK_BP" name="bus:NameEntityOfficer">Dr S. Shridhar</ix:nonNumeric></div><div class="cln fn8" style="top:159.05pt;left:300.81pt;width:145.43pt;"></div><div class="cln fn8" style="top:170.27pt;left:159.11pt;width:141.7pt;"><ix:nonNumeric contextRef="C_BK_BQ" name="bus:NameEntityOfficer">Dr S. Jothimurugan</ix:nonNumeric></div><div class="cln fn8" style="top:170.27pt;left:300.81pt;width:145.43pt;"></div><div class="clb fn8" style="top:192.71pt;left:46.61pt;width:115.49pt;">Company number</div><div class="cln fn8" style="top:192.71pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">07579931</ix:nonNumeric></div><div class="clb fn8" style="top:215.15pt;left:46.61pt;width:115.49pt;">Registered office</div><div class="cln fn8" style="top:215.15pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_BR_BS" name="bus:AddressLine1">Orbital House</ix:nonNumeric></div><div class="cln fn8" style="top:226.38pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_BR_BS" name="bus:AddressLine2">20 Eastern Road</ix:nonNumeric></div><div class="cln fn8" style="top:237.6pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_BR_BS" name="bus:PrincipalLocation-CityOrTown">Romford</ix:nonNumeric></div><div class="cln fn8" style="top:248.82pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_BR_BS" name="bus:CountyRegion">Essex</ix:nonNumeric></div><div class="cln fn8" style="top:260.05pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C_BR_BS" name="bus:PostalCodeZip">RM1 3PJ</ix:nonNumeric></div><div class="clb fn8" style="top:282.49pt;left:46.61pt;width:115.49pt;">Accountants</div><div class="cln fn8" style="top:282.49pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:NameEntityAuditors">Moore Kingston Smith LLP</ix:nonNumeric></div><div class="cln fn8" style="top:293.71pt;left:159.11pt;width:287.13pt;">Orbital House</div><div class="cln fn8" style="top:304.93pt;left:159.11pt;width:287.13pt;">20 Eastern Road</div><div class="cln fn8" style="top:316.15pt;left:159.11pt;width:287.13pt;">Romford</div><div class="cln fn8" style="top:327.38pt;left:159.11pt;width:287.13pt;">Essex</div><div class="cln fn8" style="top:338.6pt;left:159.11pt;width:287.13pt;">RM1 3PJ</div><div class="clb fn8" style="top:361.04pt;left:46.61pt;width:115.49pt;">Business address</div><div class="cln fn8" style="top:361.04pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:AddressLine1">300 Upper Rainham Road</ix:nonNumeric></div><div class="cln fn8" style="top:372.26pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:PrincipalLocation-CityOrTown">Hornchurch</ix:nonNumeric></div><div class="cln fn8" style="top:383.48pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:CountyRegion">Essex</ix:nonNumeric></div><div class="cln fn8" style="top:394.71pt;left:159.11pt;width:287.13pt;"><ix:nonNumeric contextRef="C" name="bus:PostalCodeZip">RM12 4EQ</ix:nonNumeric></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn5" style="top:40.01pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="cln fn5" style="top:54.9pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:69.79pt;left:46.61pt;width:420.77pt;">Contents</div><div class="cln fn7" style="top:82.2pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:88.15pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn8" style="top:136.6pt;left:344.32pt;width:117.98pt;">Page</div><div class="cln fn8" style="top:170.27pt;left:89.49pt;width:254.81pt;">Balance sheet</div><div class="cln fn8" style="top:170.27pt;left:344.32pt;width:114.98pt;">1</div><div class="cln fn8" style="top:215.15pt;left:89.49pt;width:254.81pt;">Notes to the financial statements</div><div class="cln fn8" style="top:215.15pt;left:344.32pt;width:114.98pt;">2 - 4</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn5" style="top:40.01pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="cln fn5" style="top:54.9pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:69.79pt;left:46.61pt;width:420.77pt;">Balance Sheet </div><div class="cln fn7" style="top:82.2pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:88.15pt;left:46.61pt;width:420.77pt;">As at <ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="bus:BalanceSheetDate">30 September 2019</ix:nonNumeric></div><div class="cln fn6" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:112.97pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="crn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">Page 1</div><div class="clb fn8" style="top:126.57pt;left:296.45pt;width:59.56pt;">2019</div><div class="clb fn8" style="top:126.57pt;left:409.57pt;width:59.55pt;">2018</div><div class="ccb fn8" style="top:137.79pt;left:199.49pt;width:43.39pt;">Notes</div><div class="crb fn8" style="top:137.79pt;left:236.88pt;width:59.56pt;">£</div><div class="crb fn8" style="top:137.79pt;left:293.45pt;width:59.56pt;">£</div><div class="crb fn8" style="top:137.79pt;left:350.01pt;width:59.55pt;">£</div><div class="crb fn8" style="top:137.79pt;left:406.57pt;width:59.55pt;">£</div><div class="cln fn9" style="top:137.79pt;left:466.77pt;width:0.65pt;"></div><div class="clb fn8" style="top:160.23pt;left:46.61pt;width:365.95pt;">Fixed assets</div><div class="cln fn8" style="top:171.45pt;left:46.61pt;width:152.88pt;">Investments</div><div class="ccb fn8" style="top:171.45pt;left:199.49pt;width:43.39pt;">2</div><div class="crn fn8" style="top:171.45pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:InvestmentsFixedAssets">160,650</ix:nonFraction></div><div class="crn fn8" style="top:171.45pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:InvestmentsFixedAssets">160,650</ix:nonFraction></div><div class="clb fn8" style="top:193.9pt;left:46.61pt;width:196.27pt;">Current assets</div><div class="cln fn8" style="top:205.12pt;left:46.61pt;width:152.88pt;">Debtors</div><div class="ccb fn8" style="top:205.12pt;left:199.49pt;width:43.39pt;">4</div><div class="crn fn8" style="top:205.12pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">15,723</ix:nonFraction></div><div class="crn fn8" style="top:205.12pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">20,837</ix:nonFraction></div><div class="cln fn8" style="top:216.34pt;left:46.61pt;width:152.88pt;">Cash at bank and in hand</div><div class="crn fn8" style="top:216.34pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" name="core:CashBankOnHand">663</ix:nonFraction></div><div class="crn fn8" style="top:216.34pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" name="core:CashBankOnHand">31</ix:nonFraction></div><div class="cln fn0 sln" style="top:232.53pt;left:265.25pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:232.53pt;left:378.38pt;width:31.19pt;"></div><div class="crn fn8" style="top:238.78pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">16,386</ix:nonFraction></div><div class="crn fn8" style="top:238.78pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">20,868</ix:nonFraction></div><div class="clb fn8" style="top:250.01pt;left:46.61pt;width:155.88pt;">Creditors: amounts falling due within one year</div><div class="ccb fn8" style="top:259.94pt;left:199.49pt;width:43.39pt;">5</div><div class="crn fn8" style="top:259.94pt;left:242.76pt;width:56.56pt;">(<ix:nonFraction contextRef="B_CF_DE" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">52,063</ix:nonFraction>)</div><div class="crn fn8" style="top:259.94pt;left:355.88pt;width:56.55pt;">(<ix:nonFraction contextRef="E_CF_DE" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">52,063</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:276.12pt;left:265.25pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:276.12pt;left:378.38pt;width:31.19pt;"></div><div class="clb fn8" style="top:282.38pt;left:46.61pt;width:252.84pt;">Net current liabilities</div><div class="crn fn8" style="top:282.38pt;left:299.33pt;width:56.56pt;">(<ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">35,677</ix:nonFraction>)</div><div class="crn fn8" style="top:282.38pt;left:412.44pt;width:56.55pt;">(<ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">31,195</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:298.57pt;left:321.82pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:298.57pt;left:434.94pt;width:31.19pt;"></div><div class="clb fn8" style="top:304.82pt;left:46.61pt;width:196.27pt;">Total assets less current liabilities</div><div class="crn fn8" style="top:304.82pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">124,973</ix:nonFraction></div><div class="crn fn8" style="top:304.82pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">129,455</ix:nonFraction></div><div class="cln fn0 dln" style="top:321.01pt;left:321.82pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:321.01pt;left:434.94pt;width:31.19pt;"></div><div class="clb fn8" style="top:338.49pt;left:46.61pt;width:155.88pt;">Capital and reserves</div><div class="cln fn8" style="top:349.71pt;left:46.61pt;width:152.88pt;">Called up share capital</div><div class="ccb fn8" style="top:349.71pt;left:199.49pt;width:43.39pt;">6</div><div class="crn fn8" style="top:349.71pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B_DF_DG" decimals="0" scale="0" unitRef="GBP" name="core:Equity">60</ix:nonFraction></div><div class="crn fn8" style="top:349.71pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E_DF_DG" decimals="0" scale="0" unitRef="GBP" name="core:Equity">60</ix:nonFraction></div><div class="cln fn8" style="top:360.93pt;left:46.61pt;width:152.88pt;">Profit and loss reserves</div><div class="ccb fn8" style="top:360.93pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn8" style="top:360.93pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B_DF_DH" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">124,913</ix:nonFraction></div><div class="crn fn8" style="top:360.93pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E_DF_DH" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">129,395</ix:nonFraction></div><div class="cln fn0 sln" style="top:377.12pt;left:321.82pt;width:31.19pt;"></div><div class="cln fn0 sln" style="top:377.12pt;left:434.94pt;width:31.19pt;"></div><div class="clb fn8" style="top:383.38pt;left:46.61pt;width:196.27pt;">Total equity</div><div class="crn fn8" style="top:383.38pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">124,973</ix:nonFraction></div><div class="crn fn8" style="top:383.38pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">129,455</ix:nonFraction></div><div class="cln fn0 dln" style="top:399.57pt;left:321.82pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:399.57pt;left:434.94pt;width:31.19pt;"></div><div class="cln" style="top:417pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:EntityHasTakenExemptionUnderCompaniesActInNotPublishingItsOwnProfitLossAccountTruefalse"><span class="fn8"><ix:exclude>The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.</ix:exclude><span style="display:none">true</span></span></ix:nonNumeric></p></div><div class="cln" style="top:449pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatCompanyEntitledToExemptionFromAuditUnderSection477CompaniesAct2006RelatingToSmallCompanies"><span class="fn8">For the financial year ended 30 September 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.</span></ix:nonNumeric></p></div><div class="cln" style="top:481pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatDirectorsAcknowledgeTheirResponsibilitiesUnderCompaniesAct" continuedAt="C_DZ_0"><span class="fn8">T</span></ix:nonNumeric><span class="fn8"></span><ix:continuation id="C_DZ_0"><span class="fn8">he directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.</span></ix:continuation></p></div><div class="cln" style="top:514pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatMembersHaveNotRequiredCompanyToObtainAnAudit" continuedAt="C_EA_0"><span class="fn8">T</span></ix:nonNumeric><span class="fn8"></span><ix:continuation id="C_EA_0" continuedAt="C_EA_1"><span class="fn8">he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476</span></ix:continuation><span class="fn8"></span><ix:continuation id="C_EA_1"><span class="fn8">.</span></ix:continuation></p></div><div class="cln" style="top:546pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatAccountsHaveBeenPreparedInAccordanceWithProvisionsSmallCompaniesRegime"><span class="fn8">These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies&apos; regime.</span></ix:nonNumeric></p></div><div class="cjn fn8" style="top:578.04pt;left:46.61pt;width:419.51pt;">The financial statements were approved by the board of directors and authorised for issue on <ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="core:DateAuthorisationFinancialStatementsForIssue">5 May 2020</ix:nonNumeric> and are signed on its behalf by:</div><div class="cln fn8" style="top:632.85pt;left:46.61pt;width:419.51pt;"><ix:nonNumeric contextRef="C_BK_BO" name="core:DirectorSigningFinancialStatements"></ix:nonNumeric>Dr N. Rao</div><div class="clb fn8" style="top:644.07pt;left:46.61pt;width:422.51pt;">Director</div><div class="clb fn8" style="top:666.52pt;left:46.61pt;width:422.51pt;">Company Registration No. 07579931</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn5" style="top:40.01pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="cln fn5" style="top:54.9pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:69.79pt;left:46.61pt;width:420.77pt;">Notes to the Financial Statements </div><div class="cln fn7" style="top:82.2pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:88.15pt;left:46.61pt;width:420.77pt;">For the year ended 30 September 2019</div><div class="cln fn6" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:112.97pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="crn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">Page 2</div><div class="clb fn8" style="top:126.57pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn8" style="top:126.57pt;left:67.73pt;width:402.65pt;">Accounting policies</div><div class="cln fn9" style="top:126.57pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn8" style="top:149.01pt;left:67.73pt;width:402.65pt;">Company information</div><div class="cln" style="top:160pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Maylands Healthcare Limited is a</span><span class="fn8"> private </span><span class="fn8">company</span><span class="fn8"> limited by shares</span><span class="fn8"> incorporated in England and Wales.</span><span class="fn8"> </span><span class="fn8">The registered office is</span><span class="fn8"> Orbital House, 20 Eastern Road, Romford, Essex, RM1 3PJ.</span></p></div><div class="clb fn8" style="top:192.6pt;left:46.61pt;width:24.12pt;">1.1</div><div class="clb fn8" style="top:192.6pt;left:67.73pt;width:402.65pt;">Accounting convention</div><div class="cln" style="top:204pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:StatementComplianceWithApplicableReportingFramework"><span class="fn8">These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.</span></ix:nonNumeric></p></div><div class="cln" style="top:255pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">The financial statements are prepared in</span><span class="fn8"> sterling</span><span class="fn8">, which is the functional currency of the company. </span><span class="fn8">Monetary a</span><span class="fn8">mounts </span><span class="fn8">in these financial statements are </span><span class="fn8">rounded to the nearest pound.</span></p></div><div class="cln" style="top:287pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:GeneralDescriptionBasisMeasurementUsedInPreparingFinancialStatements"><span class="fn8">The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.</span></ix:nonNumeric></p></div><div class="clb fn8" style="top:329.42pt;left:46.61pt;width:24.12pt;">1.2</div><div class="clb fn8" style="top:329.42pt;left:67.73pt;width:402.65pt;">Investments</div><div class="cln" style="top:340pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DescriptionMethodsUsedToAccountForInvestmentsInSubsidiariesAssociatesJointVenturesInSeparateFinancialStatements"><span class="fn8">Fixed asset investments are stated at cost less provision for diminution in value.</span></ix:nonNumeric></p></div><div class="clb fn8" style="top:362.66pt;left:46.61pt;width:24.12pt;">1.3</div><div class="clb fn8" style="top:362.66pt;left:67.73pt;width:402.65pt;">Cash and cash equivalents</div><div class="cln" style="top:374pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CashCashEquivalentsPolicy" continuedAt="C_EB_0"><span class="fn8">Cash at bank and in hand </span></ix:nonNumeric><span class="fn8"></span><ix:continuation id="C_EB_0" continuedAt="C_EB_1"><span class="fn8">are basic financial assets</span></ix:continuation><span class="fn8"></span><ix:continuation id="C_EB_1" continuedAt="C_EB_2"><span class="fn8"> and</span></ix:continuation><span class="fn8"></span><ix:continuation id="C_EB_2"><span class="fn8"> include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.</span></ix:continuation></p></div><div class="clb fn8" style="top:415.75pt;left:46.61pt;width:24.12pt;">1.4</div><div class="clb fn8" style="top:415.75pt;left:67.73pt;width:402.65pt;">Financial instruments</div><div class="cln" style="top:427pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:FinancialInstrumentsClassificationPolicy"><span class="fn8">All of the company&apos;s financial assets and liabilities are basic and measured at amortised cost.</span></ix:nonNumeric></p></div><div class="clb fn8" style="top:448.98pt;left:46.61pt;width:24.12pt;">1.5</div><div class="clb fn8" style="top:448.98pt;left:67.73pt;width:402.65pt;">Equity instruments</div><div class="cln" style="top:460pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.</span></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn5" style="top:40.01pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="cln fn5" style="top:54.9pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:69.79pt;left:46.61pt;width:420.77pt;">Notes to the Financial Statements (Continued)</div><div class="cln fn7" style="top:82.2pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:88.15pt;left:46.61pt;width:420.77pt;">For the year ended 30 September 2019</div><div class="cln fn6" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:112.97pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="crn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">Page 3</div><div class="clb fn8" style="top:126.57pt;left:46.61pt;width:24.12pt;">2</div><div class="clb fn8" style="top:126.57pt;left:67.73pt;width:400.78pt;">Fixed asset investments</div><div class="crb fn8" style="top:137.79pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn8" style="top:137.79pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn8" style="top:149.01pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn8" style="top:149.01pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn9" style="top:149.01pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn8" style="top:171.45pt;left:67.73pt;width:284.66pt;">Investments</div><div class="crn fn8" style="top:171.45pt;left:352.39pt;width:56.56pt;">160,650</div><div class="crn fn8" style="top:171.45pt;left:408.95pt;width:58.43pt;">160,650</div><div class="cln fn0 dln" style="top:187.64pt;left:377.76pt;width:31.19pt;"></div><div class="cln fn0 dln" style="top:187.64pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn8" style="top:205.12pt;left:67.73pt;width:395.19pt;">Movements in fixed asset investments</div><div class="crb fn8" style="top:216.34pt;left:400.36pt;width:67.02pt;">Shares in group undertakings</div><div class="crb fn8" style="top:247.42pt;left:400.36pt;width:67.02pt;">£</div><div class="clb fn8" style="top:258.64pt;left:67.73pt;width:395.19pt;">Cost or valuation</div><div class="cln fn8" style="top:269.86pt;left:67.73pt;width:335.63pt;">At 1 October 2018 &amp; 30 September 2019</div><div class="crn fn8" style="top:269.86pt;left:403.36pt;width:64.02pt;">160,650</div><div class="cln fn0 sln" style="top:286.05pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn8" style="top:292.31pt;left:67.73pt;width:395.19pt;">Carrying amount</div><div class="cln fn8" style="top:303.53pt;left:67.73pt;width:335.63pt;">At 30 September 2019</div><div class="crn fn8" style="top:303.53pt;left:403.36pt;width:64.02pt;">160,650</div><div class="cln fn0 dln" style="top:319.71pt;left:436.19pt;width:31.19pt;"></div><div class="cln fn8" style="top:325.97pt;left:67.73pt;width:335.63pt;">At 30 September 2018</div><div class="crn fn8" style="top:325.97pt;left:403.36pt;width:64.02pt;">160,650</div><div class="cln fn0 dln" style="top:342.16pt;left:436.19pt;width:31.19pt;"></div><div class="clb fn8" style="top:359.64pt;left:46.61pt;width:24.12pt;">3</div><div class="clb fn8" style="top:359.64pt;left:67.73pt;width:400.75pt;">Subsidiaries</div><div class="cln" style="top:382pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8" style="font-weight:bold;">Holdings of more than 20%</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">The company holds more than 20% of the share capital of the following companies:</span></p></div><div class="clb fn8" style="top:414.02pt;left:67.73pt;width:108.65pt;">Name of undertaking</div><div class="clb fn8" style="top:414.02pt;left:173.38pt;width:67.02pt;">Registered</div><div class="clb fn8" style="top:414.02pt;left:237.4pt;width:116.12pt;">Nature of business</div><div class="clb fn8" style="top:414.02pt;left:350.52pt;width:53.34pt;">Class of</div><div class="ccb fn8" style="top:414.02pt;left:400.85pt;width:67.63pt;">% Held</div><div class="clb fn8" style="top:425.24pt;left:173.38pt;width:180.14pt;">office</div><div class="clb fn8" style="top:425.24pt;left:350.52pt;width:53.34pt;">shares held</div><div class="crb fn8" style="top:425.24pt;left:397.85pt;width:35.31pt;">Direct</div><div class="crb fn8" style="top:425.24pt;left:430.17pt;width:37.22pt;">Indirect</div><div class="cln fn9" style="top:425.24pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn8" style="top:447.69pt;left:67.73pt;width:105.65pt;"><ix:nonNumeric contextRef="C_DI_DJ" name="core:NameSubsidiary">Maylands Enterprises Limited</ix:nonNumeric></div><div class="cln fn8" style="top:447.69pt;left:173.38pt;width:64.02pt;">England &amp; Wales</div><div class="cln fn8" style="top:447.69pt;left:237.4pt;width:113.12pt;"><ix:nonNumeric contextRef="C_DI_DJ" name="core:DescriptionNatureBusinessSubsidiary">Provision of medical services</ix:nonNumeric></div><div class="cln fn8" style="top:447.69pt;left:350.52pt;width:50.34pt;"><ix:nonNumeric contextRef="C_DI_DJ_DK_DL" name="core:DescriptionClassShareHeldInSubsidiary">Ordinary</ix:nonNumeric></div><div class="crn fn8" style="top:447.69pt;left:400.85pt;width:32.31pt;">50.00</div><div class="crn fn8" style="top:457.61pt;left:433.17pt;width:34.22pt;"><ix:nonFraction contextRef="C_DI_DJ" unitRef="Pure" decimals="2" scale="-2" format="ixt:numcommadot" name="core:VotingPowerInSubsidiaryIfDifferentFromOwnershipInterestPercent">0</ix:nonFraction></div><div class="cjn fn8" style="top:480.06pt;left:67.73pt;width:397.75pt;">The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:</div><div class="clb fn8" style="top:512.43pt;left:67.73pt;width:108.65pt;">Name of undertaking</div><div class="crb fn8" style="top:512.43pt;left:234.4pt;width:59.56pt;">Profit/(Loss)</div><div class="crb fn8" style="top:512.43pt;left:290.96pt;width:59.56pt;">Capital and Reserves</div><div class="cln fn9" style="top:512.43pt;left:351.16pt;width:0.65pt;"></div><div class="cln fn8" style="top:544.8pt;left:67.73pt;width:169.66pt;"><ix:nonNumeric contextRef="C_DI_DJ" name="core:NameSubsidiary">Maylands Enterprises Limited</ix:nonNumeric></div><div class="crn fn8" style="top:544.8pt;left:240.27pt;width:56.56pt;">(59,001)</div><div class="crn fn8" style="top:544.8pt;left:296.83pt;width:56.56pt;">(160,078)</div><div class="cln" style="top:567pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">The investment in Maylands Enterprises Limited includes £150 (2018: £150) ordinary shares and £160,500 (2018: £160,500) capital loan.</span></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn5" style="top:40.01pt;left:46.61pt;width:420.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">Maylands Healthcare Limited</ix:nonNumeric></div><div class="cln fn5" style="top:54.9pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:69.79pt;left:46.61pt;width:420.77pt;">Notes to the Financial Statements (Continued)</div><div class="cln fn7" style="top:82.2pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn6" style="top:88.15pt;left:46.61pt;width:420.77pt;">For the year ended 30 September 2019</div><div class="cln fn6" style="top:100.56pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:112.97pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="crn fn1" style="top:701.96pt;left:46.61pt;width:420.77pt;">Page 4</div><div class="clb fn8" style="top:126.57pt;left:46.61pt;width:24.12pt;">4</div><div class="clb fn8" style="top:126.57pt;left:67.73pt;width:231.1pt;">Debtors</div><div class="crb fn8" style="top:137.79pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn8" style="top:137.79pt;left:405.95pt;width:61.43pt;">2018</div><div class="clb fn8" style="top:149.01pt;left:67.73pt;width:174.54pt;">Amounts falling due within one year:</div><div class="crb fn8" style="top:149.01pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn8" style="top:149.01pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn9" style="top:149.01pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn8" style="top:171.45pt;left:67.73pt;width:171.54pt;">Corporation tax recoverable</div><div class="crn fn8" style="top:171.45pt;left:352.39pt;width:56.56pt;">-</div><div class="crn fn8" style="top:171.45pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_CF_DE" decimals="0" scale="0" unitRef="GBP" name="core:CorporationTaxRecoverable">827</ix:nonFraction></div><div class="cln fn8" style="top:182.67pt;left:67.73pt;width:171.54pt;">Other debtors</div><div class="crn fn8" style="top:182.67pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_CF_DE" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherDebtors">15,723</ix:nonFraction></div><div class="crn fn8" style="top:182.67pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_CF_DE" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherDebtors">20,010</ix:nonFraction></div><div class="cln fn0 sln" style="top:198.86pt;left:382.56pt;width:26.39pt;"></div><div class="cln fn0 sln" style="top:198.86pt;left:441pt;width:26.39pt;"></div><div class="crn fn8" style="top:205.12pt;left:352.39pt;width:56.56pt;">15,723</div><div class="crn fn8" style="top:205.12pt;left:408.95pt;width:58.43pt;">20,837</div><div class="cln fn0 dln" style="top:221.3pt;left:382.56pt;width:26.39pt;"></div><div class="cln fn0 dln" style="top:221.3pt;left:441pt;width:26.39pt;"></div><div class="clb fn8" style="top:238.78pt;left:46.61pt;width:24.12pt;">5</div><div class="clb fn8" style="top:238.78pt;left:67.73pt;width:287.66pt;">Creditors: amounts falling due within one year</div><div class="crb fn8" style="top:250.01pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn8" style="top:250.01pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn8" style="top:261.23pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn8" style="top:261.23pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn9" style="top:261.23pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn8" style="top:283.68pt;left:67.73pt;width:228.1pt;">Other creditors</div><div class="crn fn8" style="top:283.68pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_CF_DE" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">52,063</ix:nonFraction></div><div class="crn fn8" style="top:283.68pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_CF_DE" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherCreditors">52,063</ix:nonFraction></div><div class="cln fn0 dln" style="top:299.86pt;left:382.56pt;width:26.39pt;"></div><div class="cln fn0 dln" style="top:299.86pt;left:441pt;width:26.39pt;"></div><div class="clb fn8" style="top:317.34pt;left:46.61pt;width:24.12pt;">6</div><div class="clb fn8" style="top:317.34pt;left:67.73pt;width:287.66pt;">Called up share capital</div><div class="crb fn8" style="top:328.56pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn8" style="top:328.56pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn8" style="top:339.78pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn8" style="top:339.78pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn9" style="top:339.78pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn8" style="top:351.01pt;left:67.73pt;width:287.66pt;">Ordinary share capital</div><div class="clb fn8" style="top:362.23pt;left:67.73pt;width:400.78pt;">Issued and fully paid</div><div class="cln fn8" style="top:373.45pt;left:67.73pt;width:228.1pt;">10 Ordinary A shares of £1 each</div><div class="crn fn8" style="top:373.45pt;left:352.39pt;width:56.56pt;">10</div><div class="crn fn8" style="top:373.45pt;left:408.95pt;width:58.43pt;">10</div><div class="cln fn8" style="top:384.68pt;left:67.73pt;width:228.1pt;">10 Ordinary B shares of £1 each</div><div class="crn fn8" style="top:384.68pt;left:352.39pt;width:56.56pt;">10</div><div class="crn fn8" style="top:384.68pt;left:408.95pt;width:58.43pt;">10</div><div class="cln fn8" style="top:395.9pt;left:67.73pt;width:228.1pt;">10 Ordinary C shares of £1 each</div><div class="crn fn8" style="top:395.9pt;left:352.39pt;width:56.56pt;">10</div><div class="crn fn8" style="top:395.9pt;left:408.95pt;width:58.43pt;">10</div><div class="cln fn8" style="top:407.12pt;left:67.73pt;width:228.1pt;">10 Ordinary D shares of £1 each</div><div class="crn fn8" style="top:407.12pt;left:352.39pt;width:56.56pt;">10</div><div class="crn fn8" style="top:407.12pt;left:408.95pt;width:58.43pt;">10</div><div class="cln fn8" style="top:418.34pt;left:67.73pt;width:228.1pt;">10 Ordinary E shares of £1 each</div><div class="crn fn8" style="top:418.34pt;left:352.39pt;width:56.56pt;">10</div><div class="crn fn8" style="top:418.34pt;left:408.95pt;width:58.43pt;">10</div><div class="cln fn8" style="top:429.56pt;left:67.73pt;width:228.1pt;">10 Ordinary F shares of £1 each</div><div class="crn fn8" style="top:429.56pt;left:352.39pt;width:56.56pt;">10</div><div class="crn fn8" style="top:429.56pt;left:408.95pt;width:58.43pt;">10</div><div class="cln fn0 sln" style="top:445.75pt;left:382.56pt;width:26.39pt;"></div><div class="cln fn0 sln" style="top:445.75pt;left:441pt;width:26.39pt;"></div><div class="crn fn8" style="top:452.01pt;left:352.39pt;width:56.56pt;">60</div><div class="crn fn8" style="top:452.01pt;left:408.95pt;width:58.43pt;">60</div><div class="cln fn0 dln" style="top:468.19pt;left:382.56pt;width:26.39pt;"></div><div class="cln fn0 dln" style="top:468.19pt;left:441pt;width:26.39pt;"></div><div class="cln" style="top:485pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">All ordinary shares have attached to them full voting, dividend and capital distribution rights (including on winding up), and do not confer any rights of redemption. The shares rank pari passu in all respects save that dividends may be declared at different rates on the different share classes.</span></p></div><div class="clb fn8" style="top:527.54pt;left:46.61pt;width:24.12pt;">7</div><div class="clb fn8" style="top:527.54pt;left:67.73pt;width:402.65pt;">Directors' transactions</div><div class="cln" style="top:550pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Included in other debtors at the year end is an amount of £15,723 (2018: £20,010) due from Maylands Healthcare Medical Practice of which some of the directors are partners.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Included in other creditors are amounts due to the directors as follows:</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Dr H Carruthers £25,223 (2018: £25,223) </span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Dr S Jothimurugan £1,613 (2018: £1,613)</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Dr S Shridhar £18,535 (2018: £18,535)</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Dr N Rao £1,535 (2018: £1,535)</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">Dr A Aggarwal £1,535 (2018: £1,535)</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn8">&#160;</span></p></div></div><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="B" name="bus:EndDateForPeriodCoveredByReport">2019-09-30</ix:nonNumeric><ix:nonNumeric contextRef="B" name="bus:StartDateForPeriodCoveredByReport">2018-10-01</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityDormantTruefalse">false</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityTradingStatus"></ix:nonNumeric><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="aurep:DateAuditorsReport">05 May 2020</ix:nonNumeric><ix:nonNumeric contextRef="C_DO_DP" name="bus:LegalFormEntity"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:NameProductionSoftware">CCH Software</ix:nonNumeric><ix:nonNumeric contextRef="C_DQ_DR" name="bus:ApplicableLegislation"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:VersionProductionSoftware">CCH Accounts Production 2020.100</ix:nonNumeric><ix:nonNumeric contextRef="C_DS_DT" name="bus:AccountingStandardsApplied"></ix:nonNumeric><ix:nonNumeric contextRef="C_DU_DV" name="bus:AccountsStatusAuditedOrUnaudited"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:DescriptionPrincipalActivities">No description of principal activity</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:ScopeAccounts"></ix:nonNumeric><ix:nonNumeric contextRef="C_BK_BL" name="bus:NameEntityOfficer">Dr A. Aggarwal</ix:nonNumeric><ix:nonNumeric contextRef="C_BK_DM" name="bus:NameEntityOfficer">Dr H. Jenkins</ix:nonNumeric><ix:nonNumeric contextRef="C_BK_BN" name="bus:NameEntityOfficer">Dr H. Jenkins</ix:nonNumeric><ix:nonNumeric contextRef="C_BK_BO" name="bus:NameEntityOfficer">Dr N. Rao</ix:nonNumeric><ix:nonNumeric contextRef="C_BK_BP" name="bus:NameEntityOfficer">Dr S. Shridhar</ix:nonNumeric><ix:nonNumeric contextRef="C_DX_DY" name="bus:AccountsTypeFullOrAbbreviated"></ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.frc.org.uk/FRS-102/2019-01-01/FRS-102-2019-01-01.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BK_BL"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BK_BN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director3</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BK_BO"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director4</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BK_BP"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director5</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BK_BQ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director6</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BK_DM"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director2</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_BR_BS"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityContactTypeDimension">bus:RegisteredOffice</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_CF_DE"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_CF_DE"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_DF_DG"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_DF_DG"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_DF_DH"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_DF_DH"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_DI_DJ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:SubsidiariesDimension">core:Subsidiary1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_DI_DJ_DK_DL"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:SubsidiariesDimension">core:Subsidiary1</xbrldi:explicitMember><xbrldi:typedMember dimension="core:X-DetailsSharesHeldInSubsidiaryGroupingDimension"><core:DetailsOfSharesHeldInSubsidiaryGroupingDimension.domain>1</core:DetailsOfSharesHeldInSubsidiaryGroupingDimension.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_DO_DP"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:LegalFormEntityDimension">bus:PrivateLimitedCompanyLtd</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_DQ_DR"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:ApplicableLegislationDimension">bus:SmallCompaniesRegimeForAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_DS_DT"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountingStandardsDimension">bus:FRS102</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_DU_DV"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsStatusDimension">bus:AuditExemptWithAccountantsReport</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_DX_DY"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">07579931</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsTypeDimension">bus:FullAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="GBP"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit></ix:resources></ix:header></div></body></html>